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A series of survivor cell lines derived by infection of B103 rat neuroma cells with 
active wild-type herpes simplex virus type 1 (HSV-1) (M. Levine, A. L. Goldin, and 
J. C. Glorioso, J. lrird 35,203-210 (1980)) has been isolated. The survivor cells produced 
no infectious virus, yet they continued to react with HSV-1 antiserum for over 100 cell 
generations following the initial infection. The reactivity of the survivor cells with 
HSV-1 antiserum is characterized as being due to expression of a 51K protein. The 51K 
protein reacted with antiserum prepared against HSV-1 virions and was not detectable 
in the parental B103 cells. A protein of the same molecular weight was seen in 
productively infected B103 and HEL cells. The protein detected in the survivor cells 
comigrated with that seen in the infected cells on two-dimensional gel eleetrophoresis, 
indicating that they represent similar proteins. Despite the presence of the 51K protein 
reactive with HSV-1 antiserum, the survivor cells contain no detectable HSV-1 DNA 
sequences. They do contain DNA sequences which cross-hybridize with HSV-1 DNA, 
but similar cross-hybridizing sequences were also present in the parental B103 cells. No 
hybridizing polysomal, polyadenylated RNA species were present in the survivor cells 
that were not present in the parental B103 cells when probed with the cross-hybridizing 
HSV-1 restriction fragments. Therefore, the 51K protein evidently represents a cellular 
protein induced by the HSV-1 infection. o 1985 Academic PMS, IN 
Herpes simplex viruses types 1 and 2 
(HSV-1 and HSV-2) interact uniquely with 
neuronal cells in viva to result in latent 
infections (1, 3, 2). These latent infections 
have been demonstrated experimentally 
in mice, rabbits, and guinea pigs and 
represent the usual course of events in 
humans (4, 3). The mechanism by which 
a latent infection is maintained is un- 
known, but it has been demonstrated that 
the dormant virus is harbored in the 
neuronal cell bodies of sensory ganglia 
(5, 3). 
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We have been studying the interaction 
of HSV-1 with a rat neuroma cell line 
called B103 (6). B103 cells were nonper- 
missive for growth of the KOS strain of 
HSV-1 (Y), and this nonpermissivity was 
most pronounced at elevated temperature 
and low multiplicity of infection (8). When 
B103 cells were infected with HSV-1 
(KOS) under the least permissive condi- 
tions, about 10% of the cells survived the 
infection. These survivor cells ceased to 
produce any infectious virus by 14 days 
postinfection, and grew as well as the 
original B103 cell line. The survivor cells 
were distinguishable from the parental 
B103 cells, however, in that they reacted 
with HSV-1 antiserum as measured by 
immunofluorescence. This apparent he- 
reditary change, plus, preliminary data 
suggesting complementation of superin- 
fecting temperature-sensitive mutant vi- 
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rus and the presence of DNA sequences 
which hybridize to viral DNA, led us to 
propose that at least a portion of the 
HSV-1 genome is harbored in these sur- 
vivor cells (8). 
To determine what specific proteins in 
the survivor cells were reactive with HSV- 
1 antiserum, the cell extracts were ana- 
lyzed by the Western transfer technique 
(9). The survivor cell lines used in this 
experiment were an uncloned survivor cell 
population, KOS-survivor-l, and a cloned 
survivor cell line, KOS-Survivor-2.7, de- 
rived from KOS-Survivor-2. Cellular ly- 
sates prepared for protein analysis were 
electrophoresed in SDS-polyacrylamide 
gels and then electroblotted onto nitro- 
cellulose. The resulting filters were reacted 
with antiserum prepared against HSV-1 
virions, then treated with ‘%I-labeled 
Staphylococcus aureus protein A and au- 
toradiographed (Fig. 1). Neither unin- 
fected B103 cells nor uninfected HEL cells 
contained any proteins reactive with the 
anti-HSV-1 antibody. Both survivor cell 
lines expressed a series of proteins that 
reacted with the HSV-1 antiserum. One 
predominant protein migrating with the 
apparent molecular weight of 51K was 
observed, along with three minor species 
between 46K and 49K. A protein that 
comigrated with the 51K protein was also 
present in all of the cell lines infected 
with HSV-1 including B103- and HEL- 
infected cells. A similar protein has not 
been observed in uninfected B103 cells, 
however, even when the autoradiograph 
was exposed for 2 weeks instead of the 4- 
day exposure shown in Fig. 1. As a control, 
preimmune serum failed to react with a 
51K protein from either survivor or in- 
fected cells (data not shown). 
To confirm that the 51K protein seen in 
infected cells was the same as that seen 
in survivor cells, lysates of infected and 
survivor cells were examined by two-di- 
mensional gel electrophoresis followed by 
Western transfers. The lysates were elec- 
trophoresed in isoelectric focusing tube 
gels followed by a second-dimension SDS- 
polyacrylamide gel electrophoresis. The 
two-dimensional gels were then trans- 
ferred to nitrocellulose and probed with 
eapoo- 
*, * 
FIG. 1. Western transfer analysis of B103 and 
survivor cell proteins. Cellular lysates were electro- 
phoresed in a 10% polyacrylamide-SDS gel, elec- 
troblotted onto nitrocellulose, probed with antiserum 
against HSV-1 virions (diluted 1:lOO) followed by 
addition of ‘zI-laheled S uureus protein A (2 X 10’ 
dpm/ml) and autoradiographed as described previ- 
ously (27-29, 9). The samples consisted of 40 pg of 
lysate from uninfected HEL, B103, KOS-Survivor-l, 
and KOS-Survivor-Z.7 cells, and either 10 or 40 pg 
of lysate from each cell line infected with HSV-1 
(KOS) at an m.o.i. = 5 for 24 hr at 37”. The markers 
consist of “C-labeled molecular-weight standards 
(New England Nuclear), and are too faint to be 
visible on this autoradiograph, which was exposed 
for 4 days. The location of the 51K protein is 
indicated (~51). Antiserum against HSV-1 (KOS) 
virions was prepared by hyperimmunization of New 
Zealand white rabbits as described previously (99). 
The extracellular virus released into the medium 
from 20 roller bottles of Vero cells infected with 
HSV-1 (KOS) at an m.o.i. of 0.1 were purified by 
differential centrifugation and sucrose gradient cen- 
trifugation. The purified virions (10”’ PFU) were 
resuspended in 5 ml of PBS and uv irradiated at 12 
ergs/mm*/sec for 20 min. Aliquotes (0.25 ml each) 
were diluted 1:l in complete Freund adjuvant and 
injected intramuscularly into the rabbits at 2-week 
intervals, for a total of eight injections, after which 
serum was collected. The serum was heated at 56” 
for 30 min to inactivate complement. 
HSV-1 antiserum as before (Fig. 2). The 
circled spots are 14C-labeled protein 
markers included as points of reference. 
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FIG. 2. Two-dimensional electrophoresis and Western transfer analysis of B103 and survivor 
cellular proteins. Lysates for two-dimensional gel electrophoresis were prepared as described by 
Haarr and Marsden (SO). Two-dimensional gel electrophoresis was performed by modifications of 
the procedures of O’Farrell (S1), and O’Farrell et &, (82), as described by Haarr and Marsden 
(.Yo). Lysates from each cell line were electrophoresed first in 3-mm tube isoelectric focusing gels 
and then in 10% polyacrylamide-SDS slab gels, electroblotted onto nitrocellulose, and probed 
with antiserum against HSV-1 virions followed by ‘251-labeled S. uureus protein A and autora- 
diography as described in the legend to Fig. 1. The samples consisted of (A) KOS-Survivor-B.7 
cells infected with HSV-1 (KOS) at an m.o.i. = 5 for 24 hr at 37’, (B) uninfected KOS-Survivor- 
2.7 cells, (C) B103 cells infected with HSV-1 (KOS) at an m.o.i. = 5 for 24 hr at 37”, and (D) 
uninfected B103 cells. On the left are shown conventional one-dimensional SDS-polyacrylamide 
gel profiles of “C-labeled molecular-weight standards (New England Nuclear) and lysate in one- 
sixth the amount loaded onto the isoelectric focusing gels. The acidic end of the isoelectric 
focusing gel is at the left. The spots with circles around them are ‘“C-labeled markers included 
as points of reference. The arrow points to the location of the 51K protein. These autoradiographs 
were exposed for 3 weeks. 
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FIG. 2-&?ttinukd 
In the uninfected KOS-Survivor-47 cell 
pattern there is a spot migrating at 51K, 
indicated by the arrow in Fig. 2B. A more 
intense spot in a similar location can be 
seen in the infected KOS-Survivor-2.7 cell 
pattern (Fig. 2A), indicating that this 
protein, presumably the 51K protein de- 
tected in the one-dimensional Westerns, 
is induced during HSV-1 infection. Similar 
induction of a protein migrating to the 
same position can be seen in the infected 
B103 cell pattern (Fig. 2C). The greater 
number of spots present in the infected 
B103 cell lysate compared to the infected 
KOS-Survivor-2.7 cell lysate reflects the 
more productive infection of B103 versus 
survivor cells. As expected, no proteins 
reactive with the antiserum are apparent 
in the uninfected B103 cell pattern (Fig. 
2D). Therefore, a 51K protein that is 
constitutively expressed in the survivor 
cells also appears to be induced by lytic 
HSV-1 infection in both the B103 and 
survivor cells. 
This stable change in the survivor cells 
suggested that the survivor cells had ac- 
FIG. 3. Southern blot hybridizations of survivor cell DNA with cloned fragments spanning the 
HSV-1 genome. (A) EcoRI restriction map of HSV-1 (KOS) showing the restriction fragments 
which were used as hybridization probes. (B) Hybridizations of the restriction fragment probes 
to EcoRI-digested B103 and survivor cell DNA. Ten micrograms of DNA from B103, KOS- 
Survivor-l, and KOS-Survivor-2.7 cells were digested with EcoRI, electrophoresed in 1% agarose, 
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quired and were expressing HSV-1 DNA 
sequences. To test this, DNA from the 
two survivor cell lines was analyzed for 
the presence of HSV-1 DNA sequences by 
Southern transfer hybridizations. Twelve 
cloned EcoRI restriction fragments rep- 
resenting the entire HSV-1 genome (IO), 
were used as hybridization probes (Fig. 
3A). The terminal fragments E, J, and K 
were not used for hybridization since they 
were represented in the joint fragments 
EK and JK. B103 and survivor cell DNA 
were digested with EcoRI, fractionated in 
1% agarose gels, and transferred to nitro- 
cellulose. As a control, unlabeled HSV-1 
DNA was added to Escherichia coli DNA 
at a level equivalent to one copy per 
haploid mammalian cell genome. Figure 
3B shows the results of hybridizations of 
parental B103, KOS-Survivor-l, and KOS- 
Survivor-2.7 DNA with gel-purified inserts 
from the 12 cloned probes. The only frag- 
ments that hybridized with the survivor 
cell DNA were EK, JK, H, and L. These 
four fragments also hybridized to a similar 
extent with B103 parental cell DNA (Fig. 
3B). These four restriction fragments of 
HSV-1 contain sequences which hybridize 
to mammalian DNA from a variety of 
species (11, 18, unpublished results). No 
additional hybridization bands other than 
those representing the cross-hybridization 
cellular sequences were detected. A similar 
analysis was performed using four addi- 
tional survivor cell lines which reacted 
with HSV-1 antiserum and in which ~51 
was detected (data not shown). Results 
similar to those described in Fig. 3B were 
obtained. No HSV-1 DNA sequences were 
detected in any of these survivor cell 
lines. 
Although the survivor cells did not ap- 
pear to contain any newly acquired HSV- 
1 DNA sequences, they did contain DNA 
sequences which cross-hybridized to HSV- 
1. The complex hybridization patterns of 
these sequences made it difficult to rule 
out the possibility that some hybridization 
bands representing acquired HSV-1 DNA 
might be present. Since any HSV-1 se- 
quences responsible for the reactivity of 
the survivor cells with HSV-1 antiserum 
would be transcribed into messenger RNA, 
presumably polyadenylated, it should be 
possible to detect the RNA transcripts of 
those sequences if they were present in 
the survivor cells. Therefore, polysomal 
oligo(dt) purified RNA was isolated from 
B103 and KOS-Survivor-Z.7 cells and an- 
alyzed by Northern transfer hybridiza- 
tions. The RNA was glyoxalated, fraction- 
ated in 1% agarose gels, transferred to 
Gene Screen (New England Nuclear 
Corp.), and hybridized to the EcoRI frag- 
ments EK, JK, H, and L. No hybridizing 
transcripts unique to the survivor cells 
were observed with any of the four HSV- 
1 probes (data not shown). This indicates 
that the survivor cells are not expressing 
any HSV-1 DNA sequences from these 
regions of the viral genome. 
The sensitivity of the Southern hybrid- 
izations probing for HSV-1 sequences in 
the survivor cells depends upon the copy 
number of the sequences in the cells and 
the size of the hybridization probes. The 
analysis was performed on a cloned sur- 
vivor line, KOS-Survivor-2.7, so that any 
HSV-1 sequences that were acquired 
would be present in every cell, equivalent 
to a level of at least one copy per cell. 
The largest hybridization probe employed 
in the analysis of the survivor cells was 
EcoRI fragment A, a 21-kb fragment. In 
previous hybridizations using a DNA 
probe of similar size we were able to 
detect a single-copy fragment at least 10% 
of the size of the hybridization probe (13). 
This level of sensitivity was demonstrated 
to be at least 6% the size of the probe in 
other experiments (unpublished results). 
Therefore, the EcoRI A fragment should 
and transferred to nitrocellulose as described previously (13). Also included was a positive control, 
indicated as HSV-1, which consisted of unlabeled HSV-1 DNA added to E. wli DNA at a level 
equivalent to one copy per haploid mammalian cell genome (2 X 10e4 gg/pg). The 12 HSV-1 EwRI 
fragments contained in the previously described chimeric plasmids (IO), were gel purified (IS), 
q-labeled by nick translation (IO), and used as hybridization probes. Each probe is indicated 
below the corresponding filter. 
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detect an HSV-1 DNA fragment of about 
1.3 kb present as a single copy in the 
survivor cells. The other hybridization 
probes should have detected correspond- 
ingly smaller HSV-1 fragments. Although 
further hybridizations with smaller probes 
would be necessary to completely exclude 
the possibility of retained HSV-1 DNA in 
the survivor cells, it does seem unlikely 
that KOS-Survivor-Z.7 cells contain HSV- 
1 DNA fragments larger than about 1.3 
kb. A protein of 51K molecular weight 
would consist of approximately 460 amino 
acids, requiring a coding capacity of 1380 
nucleotide pairs. Although not rigorously 
proven, it is unlikely that an HSV-1 DNA 
fragment this large is present in the KOS- 
Survivor-2.7 cells. Consistent with this, 
no hybridizing polysomal, polyadenylated 
RNA species were present in the survivor 
cells that were not also present in the 
parental B103 cells when probed with the 
cross-hybridizing HSV-1 restriction frag- 
ments. 
In a previous publication (8), we inter- 
preted the appearance of the new protein 
phenotype in the survivor cells as due to 
the persistence of HSV-1 genes in these 
cells. This interpretation is clearly at 
variance with the findings reported here. 
Preliminary findings suggested that the 
survivors could complement temperature- 
sensitive mutants of HSV-1 (KOS) and 
contained sequences hybridizing to HSV- 
1 DNA. The complementation indices ob- 
served were more than 2 but less than 10, 
the minimum now accepted as indicating 
complementation. The preliminary hy- 
bridization experiments were undoubtedly 
confused by the hybridization effects re- 
ported in this paper. 
A 51K protein, which appears to comi- 
grate with the 51K protein of survivor 
cells, is observed in productively infected 
B103 cells and survivor cells. These pro- 
teins migrate to the same position in two- 
dimensional gel electrophoresis followed 
by Western transfers, indicating a simi- 
larity between them. These results suggest 
that the 51K protein is a cellular protein 
that has been induced by the initial HSV- 
1 infection and is stably synthesized in 
the survivor cells. There are at least two 
explanations why such a cellular protein 
might react with antiserum prepared 
against HSV-1 virions. First, HSV-1 vi- 
rions acquire a membranous envelope by 
budding through virus-modified patches 
of the nuclear membrane (1.4, 15), so that 
cellular membrane proteins are present 
in the viral envelope (16). If the 51K 
protein represents a cell-specific mem- 
brane protein induced by HSV-1 infection 
it would likely be contained in the viral 
envelope and, consequently, be present in 
the HSV-1 antigen preparation. The sec- 
ond explanation is that the inoculations 
of virus particles into the rabbit could 
have resulted in a low level HSV-1 infec- 
tion. As detailed in the legend to Fig. 1, 
purified virions were uv irradiated, then 
aliquots containing the equivalent of 5 
x lOa plaque-forming units (PFU) were 
injected intramuscularly. Although no in- 
fectious virus was detected in this uv- 
irradiated preparation, sufficient infec- 
tious virus may have been injected to 
cause a low-level HSV-1 infection, even 
though the rabbit was not noticeably ill. 
The rabbit would then be likely to produce 
antibodies to any cellular proteins induced 
during the HSV-1 infection. 
SV40 and adenovirus induce a 53K cel- 
lular protein during transformation (ZY- 
19). This protein, termed ~53, has also 
been detected in spontaneous transfor- 
mants (20, 21) and in cells transformed 
by chemical mutagenesis (22). ~53 may be 
a cell-cycle, transformation-specific pro- 
tein (23). Epstein-Barr virus induces a 
cellular protein of 53K (24, 25), but this 
protein is not the same ~53 induced by 
SV40 and adenovirus (26). The 51K protein 
induced by HSV-1 in the survivor cells is 
not related antigenically to the SV40- 
induced ~53. No immunoreactive protein 
in the molecular-weight range of 50,000 
to 55,000 was detectable on Western 
transfers of lysates from either of two 
SV40-transformed cell lines, using the 
HSV-1 antiserum (data not shown). There 
are no data concerning the relationship 
of the 51K protein to the Epstein-Barr 
virus-induced ~53. The function of that 
~53 is not known, but it also appears to 
be related to transformation, as the pro- 
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tein is present in Epstein-Barr virus- 
transformed cells and binds Epstein-Barr 
virus nuclear antigen (25). The HSV-1 
induced 51K protein was not found in one 
HSV-1 transformed cell line (data not 
shown). Additional HSV-1 transformants 
will have to be tested to confirm its ab- 
sence. 
In conclusion, we have demonstrated 
that B103 cells which survived HSV-1 
infection express a 51K cellular protein 
that reacts with HSV-1 antiserum. This 
protein was not detected in uninfected 
B103 cells, but was induced during lytic 
HSV-1 infection of those cells and was 
stably induced in the survivor cell lines. 
No function has yet been demonstrated 
for the 51K protein, but it does not appear 
to be related to transformation by HSV- 
1. Further studies will be required to 
determine the function and significance 
of the 51K protein induced by HSV-1 in 
these neuronal survivor cell lines. 
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